Twenty-year follow-up of osteosarcoma of the extremity treated with adjuvant chemotherapy

Journal of Chemotherapy

Volumn 16, Issue 6, 2004, Pages 582-588

  Longhi, Alessandra ^a   Pasini, E ^a   Bertoni, F ^a   Pignotti, E ^a   Ferrari, C ^a   Bacci, G ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Adjuvant chemotherapy; Cardiotoxicity; Late adverse events; Long term follow up; Osteosarcoma; Second malignant neoplasm

Indexed keywords

BLEOMYCIN; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OSTEOSARCOMA; PANCYTOPENIA; RELAPSE; RISK ASSESSMENT; SECOND CANCER; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

EID: 12544251372     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.6.582     Document Type: Article

References (29)

1. Bacci G, Gherlinzoni F, Picci P, et al. Adriamycin-Methotrexate high dose versus Adriamycin-Methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study. Eur J Cancer Clin Oncol 1986; 22:1337-1345.
2. Link MP, Goorin AM, Miser AW et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314:1600-1606.
3. Rosen G, Marcove RC, Caparros B, et al. Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 1979; 43:1221-1230.
4. Campanacci M, Bacci G, Bertoni F, et al. The treatment of osteosarcoma of the extremities: twenty years experience at the Istituto Ortopedico Rizzoli. Cancer 1981; 48:1569-1581.
5. Bacci G, Ferrari S, Lari S, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg (Br) 2002; 84:88-92.
6. Kotz R, Dominkus M, Zettl T, et al. Advances in bone tumor treatment in 30 years, with respect to survival and limb salvage. A single institution experience. Int Orthoped 2002; 26:197-202.
7. Winkler K, Beron G, Kotz R. Neoadjuvant chemotherapy for osteogenic sarcoma: results of cooperative German/Austrian Study. J Clin Oncol 1984; 2:617-624.
8. Bramwell VHC, Burgers M, Sneath R, et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992; 10:5-15.
9. Souhami RL, Craft AW, Van der Eijeken JW, et al. Randomized trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350:911-917.
10. Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan Kettering experience. J Clin Oncol 1992; 10:5-15.
11. Link MP. The multiinstitutional osteosarcoma study; an update. Cancer Treat Res 1993; 62:261-267.
12. Ferrari S, Bacci G, Picci P, et al. Long term follow up and post relapse survival in patients with nonmetastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 1997; 8:765-771.
13. Fuchs N, Bielack SS, Epler D, et al. Long term results of the co-operative German Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9:893-899.
14. Geidel S, Garn M, Gravinghoff L, et al. Cardiomyopathy after osteosarcoma treatment: a contribution on the cardiotoxicity of doxorubicin. Klin Pediatr 1991; 203:257-261.
15. Howell S, Shalet S. Gonadal damage from chemotherapy and Radiotherapy. Endoc Metab Clin North Am 1998; 27:927-943.
16. Byrne J, Mulvihill JJ, Meyer MH, et al. Effects of treatment on fertility in long-term survivors oh childhood or adolescent cancer. N Engl J Med 1987; 317:1315-1321.
17. Hawkins MM. Is there evidence of a therapy related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst 1991; 83:1643-1650.
18. Longhi A, Porcu E, Petracchi S, et al. Reproductive functions in female patients treated with adjuvant and neoadjuvant chemotherapy for localized osteosarcoma of the extremity Cancer 2000; 89:1961-1965.
19. Robinson LL. Second primary cancers after childhood cancer. BMJ 1996; 312:861-862.
20. Nicholson HS, Mulvihill JJ, Byrne J. Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma. Med Pediatr Oncol 1992; 20:6-12.
21. Pratt CB, Meyer WH, Luo X, et al. Second malignant neoplasms occurring in survivors of osteosarcoma. Cancer 1997; 80:960-965.
22. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the IOR/OS 2 protocol; an updated report. J Clin Oncol 2000; 18:4016-4027.
23. Jaffe N, Smith E, Abelson HT, et al. Osteogenic sarcoma: alteration in the pattern of pulmonary metastases with adjuvant chemotherapy. J Clin Oncol 1983; 1:251-254.
24. Bacci G, Ferrari S, Longhi A, et al. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer 2001; 37:32-38.
25. Giuliano A, Feig S, Eilber FR. Changing metastatic pattern in osteosarcoma. Cancer 1984; 54:2160-2164.
26. Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 2003; 21:1574-1580.
27. Dodds L, Marrett LD, Tomkins DJ, et al. Case control study of congenital anomalies in children of cancer patients. BMJ 1993; 307:164-168.
28. Young JL, Ries LG, Silverberg E, et al. Cancer incidence, survival and mortality for children younger then age 15 years. Cancer 1986; 58:598-602.
29. Green DM, Zevon MA, Lowrie G, et al. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991; 325:141-146.